Abstract
Background Multiple adverse health outcomes have been linked to air pollution, particularly exposure to particulate matter (PM2.5).
Justification This research will help to identify the role that socioeconomic and geographical factors have in increased cardiovascular disease and cardiac events due to elevated exposure amounts of PM2.5. Minorities in the United States are more likely to have or die from cardiovascular disease and also are the majority of the occupants in low-income communities with high levels of PM2.5.
Methods PM2.5 pollutant concentrations were measured from 2016 to 2018 and collected by air quality monitoring equipment in Ohio. The cardiovascular disease data on adult residents of Ohio from 2016-2018 was from the National Vital Statistics System (NVSS) and the Centers for Medicare and Medicaid Services Medicare Provider Analysis and Review (MEDPAR). R programming was used to find associations between cardiovascular disease and PM2.5 in Ohio. Contingency tables compared the consumption of PM2.5 and the rate of heart disease mortality. Heat maps indicated areas where heart disease mortality and PM2.5 concentrations were highest.
Results The average PM2.5 concentration in Ohio was determined to be 7.9 μG/m3. The highest PM2.5 concentrations were found in Montgomery County, Ohio and the lowest were recorded in Allen County, Ohio. With increased population density, there was also an increase with PM2.5 concentrations (P<0.01). The association between cardiovascular disease mortality and PM2.5 rates in these counties was nonsignificant (P>0.01). It was also found that 31.8% of counties in Ohio had air monitoring while the remaining 68.2% did not have any form of it.
Conclusion Knowing the risk of PM2.5 levels in any neighborhood could help community members and leaders pick a more appropriate course of action. Reducing air pollutants in these areas may in turn reduce cardiovascular disease in that population, leading to better health outcomes and longevity. This research also identified gaps in air monitoring that assists in prioritizing areas that need immediate remediation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved exempt by the Geisinger Commonwealth School of Medicine IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵+ Master of Biomedical Science Program
Data Availability
All data produced in the present work are contained in the manuscript.
